Table: begin end state 1 6 cytoplasmic 7 26 transmembrane 27 48 non-cytoplasmic 49 71 transmembrane 72 79 cytoplasmic 80 99 transmembrane 100 104 non-cytoplasmic 105 129 transmembrane 130 140 cytoplasmic 141 161 transmembrane 162 166 non-cytoplasmic 167 188 transmembrane 189 234 cytoplasmic 235 256 transmembrane 257 268 non-cytoplasmic 269 288 transmembrane 289 297 cytoplasmic 298 317 transmembrane 318 322 non-cytoplasmic 323 347 transmembrane 348 357 cytoplasmic 358 378 transmembrane 379 388 non-cytoplasmic 389 409 transmembrane 410 431 cytoplasmic
Input: >BPHYT_RS11295 MTSSLAIRRWWTIMPIVFITYSLAYLDRANYGFASAAGINQDLGISKGLSSLIGALFFLG YFFFQIPGAIYAERRSVKKLVFWSLILWGACASLTGMVSNIPSLMVIRFVLGVVEAAVMP AMLIFISNWFTKSERSRANTFLILGNPVTVLWMSVVSGYLVHSFGWRHMFIAEGAPAILW AVCWWFIVKDKPQQVSWLTQQQKDDLAETLRAEQAAIKPVRNYSDAFKTPAVIKLCAQYF CWSIGVYGFVLWLPSILKNGSTLGMVETGWLSALPYLAATIAMLAASWASDKLNRRKVFV WPFLLVGAVAFAASYALGSTHFWLSYALLVIAGAAMYAPYGPFFAIVPELLPKNVAGGAM ALINSMGALGSFVGSYVVGYLNGATGSPAASYAFMSVALVTAVILTLIVKPQQQESSNAA TARHPVARKIS
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server